Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

The 21st Century Cures Act was broadly supported in the U.S. Congress for its various provisions, including increased funding for cancer research and the revision of U.S. Food and Drug Administration (FDA) standards for review. The Act authorized $4.8 billion over the next 10 years for cancer research under the Moonshot Initiative, the Precision Medicine Initiative (PMI) and FDA regulatory reform. Appropriation of those funds may prove newly problematic in light of the White House administration’s disclosed budget priorities.


Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Kalorama Information offers additional analysis of the markets discussed below with an upcoming title on clinical and research microarrays as well as published reports including The Market for Prenatal, Newborn and Carrier Genetic Testing , The World Market for Cancer Diagnostics, 6 th Ed. , Proteomics Research Markets , The World Market for Flow Cytometry in IVD Applications , and The World Market for Veterinary Diagnostics.

Thermo Fisher Scientific’s reach in the global life sciences market ...


Tech Giants Become Big Movers in Medical Research

Tech Giants Become Big Movers in Medical Research

Basic research is fundamental to the introduction of medicine, medical technologies and other marketable healthcare products. Its bewildering scope or the experimental freedom necessary for market-significant discoveries requires tremendous resources with relative inattention to profitability or return. If pharmaceuticals, medical devices and diagnostics are what emerge from the spigot of translational research workflows, basic research is the well - continually being dug deeper to access wider ...